Related Experiment Videos
Uremic toxins: new aspects.
1Department of Medicine, University of Vienna, Austria.
Journal of Nephrology
|December 29, 2000
Summary
End-stage renal failure causes symptoms due to accumulating uremic toxins like asymmetric dimethylarginine and homocysteine. Reduced kidney function, oxidative stress, and inflammation contribute to these toxin build-ups.
Area of Science:
- Nephrology
- Toxicology
- Biochemistry
Background:
- Clinical manifestations in end-stage renal failure (ESRF) are linked to the buildup of uremic retention solutes and toxins.
- These accumulating substances can lead to significant physiological derangements in patients with kidney failure.
Purpose of the Study:
- To detail the specific uremic retention solutes and toxins implicated in ESRF.
- To elucidate the mechanisms driving the accumulation of these harmful substances.
Main Methods:
- Review and description of abnormalities associated with specific uremic toxins.
- Analysis of the contributing factors to the accumulation of uremic retention solutes.
Main Results:
- Abnormalities are linked to asymmetric dimethylarginine, advanced glycation end products (AGEs), advanced lipoxidation end products (ALEs), advanced oxidation protein products (AOPPs), and homocysteine.
- Low and high molecular weight inhibitors of polymorphonuclear leukocytes are also implicated.
- Accumulation mechanisms involve decreased renal function, oxidative stress, microinflammation, and uremia-induced protein modifications.
Conclusions:
- The accumulation of diverse uremic retention solutes and toxins is a key factor in the pathophysiology of ESRF.
- Understanding these toxins and their accumulation mechanisms is crucial for managing ESRF patients.